top of page


Our products pipeline shows the current progress in our clinical programs. We are advancing personalized immunotherapies starting with our lead product of individualized neoantigen cancer vaccine against multiple cancer indications. 

DNA vials
Explore our pipeline
Phase I
Phase II
Phase III

SQK01 Neoantigen cancer vaccine (solid tumors)

Lung cancer vaccine (public vaccine design)

bottom of page